Paul Mueller Company Announces Its Third Quarter Earnings of 2022

·10 min read
Paul Mueller Company
Paul Mueller Company

SPRINGFIELD, Mo., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended September 30, 2022.

 

PAUL MUELLER COMPANY
NINE-MONTH REPORT
Unaudited
(In thousands)

CONSOLIDATED STATEMENTS OF INCOME

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

Twelve Months Ended

 

 

 

 

September 30

 

September 30

 

September 30

 

 

 

 

2022

 

2021

 

2022

 

2021

 

2022

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales

 

 

 

$

45,766

 

$

43,063

 

$

132,518

 

$

137,620

 

$

179,511

 

$

191,746

Cost of Sales

 

 

 

34,801

 

32,959

 

102,204

 

98,706

 

139,665

 

136,614

Gross Profit

 

 

 

$

10,965

 

$

10,104

 

$

30,314

 

$

38,914

 

$

39,846

 

$

55,132

Selling, General and Administrative Expense

 

 

 

9,695

 

11,267

 

30,332

 

34,128

 

40,088

 

45,127

Goodwill Impairment Expense

 

 

 

-

 

-

 

-

 

-

 

-

 

15,397

Operating Income (Loss)

 

 

 

$

1,270

 

$

(1,163)

 

$

(18)

 

$

4,786

 

$

(242)

 

$

(5,392)

Interest Expense

 

 

 

(105)

 

(102)

 

(610)

 

(644)

 

(708)

 

(817)

PPP Loan Forgiveness

 

 

 

-

 

-

 

-

 

1,884

 

-

 

1,884

Other Income (Expense)

 

 

 

38

 

(94)

 

176

 

64

 

2,956

 

403

Income (Loss) before Provision (Benefit) for Income Taxes

 

 

 

$

1,203

 

$

(1,359)

 

$

(452)

 

$

6,090

 

$

2,006

 

$

(3,922)

Provision (Benefit) for Income Taxes

 

 

 

223

 

(317)

 

(161)

 

1,051

 

335

 

2,314

Net Income (Loss)

 

 

 

$

980

 

$

(1,042)

 

$

(291)

 

$

5,039

 

$

1,671

 

$

(6,236)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (Loss) per Common Share -

 

Basic and Diluted

 

$

0.90

 

($0.96)

 

$

(0.27)

 

$

4.61

 

$

1.54

 

$

(5.58)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

 

 

 

 

 

 

Nine Months Ended

 

 

September 30

 

 

2022

 

2021

 

 

 

 

 

Net Income (Loss)

 

$

(291)

 

$

5,039

Other Comprehensive Income (Loss), Net of Tax:

 

 

 

 

Foreign Currency Translation Adjustment

 

(3,292)

 

(1,048)

Comprehensive Income (Loss)

 

$

(3,583)

 

$

3,991

 

 

 

 

 


CONSOLIDATED BALANCE SHEETS

 

 

 

 

 

 

 

September 30

 

December 31

 

 

2022

 

2021

 

 

 

 

 

Cash and Short-Term Investments

 

$

20,871

 

$

11,281

Accounts Receivable

 

20,509

 

25,774

Inventories (FIFO)

 

55,120

 

43,309

LIFO Reserve

 

(21,308)

 

(16,855)

Inventories (LIFO)

 

33,812

 

26,454

Current Net Investments in Sales-Type Leases

 

22

 

23

Other Current Assets

 

4,556

 

1,814

Current Assets

 

$

79,770

 

$

65,346

 

 

 

 

 

Net Property, Plant, and Equipment

 

38,649

 

41,250

Right of Use Assets

 

2,074

 

2,526

Other Assets

 

7,290

 

7,003

Long-Term Net Investments in Sales-Type Leases

 

251

 

164

Total Assets

 

$

128,034

 

$

116,289

 

 

 

 

 

Accounts Payable

 

$

11,186

 

$

14,470

Current Maturities and Short-Term debt

 

1,180

 

1,330

Current Lease Liabilities

 

389

 

483

Advance Billings

 

34,089

 

18,595

Other Current Liabilities

 

18,117

 

9,096

Current Liabilities

 

$

64,961

 

$

43,974

 

 

 

 

 

Long-Term Debt

 

11,924

 

14,241

Long-Term Pension Liabilities

 

15,087

 

18,036

Other Long-Term Liabilities

 

2,225

 

1,848

Lease Liabilities

 

654

 

897

Total Liabilities

 

$

94,851

 

$

78,996

Shareholders' Investment

 

33,183

 

37,293

Total Liabilities and Shareholders' Investment

 

$

128,034

 

$

116,289

 

 

 

 

 


 

 

 

 

 

SELECTED FINANCIAL DATA

 

 

 

 

 

 

 

September 30

 

December 31

 

 

2022

 

2021

Book Value per Common Share

 

$

30.56

 

$

34.32

Total Shares Outstanding

 

1,085,711

 

1,086,661

Backlog

 

$

139,177

 

$

78,357


 

CONSOLIDATED STATEMENT OF SHAREHOLDERS' INVESTMENT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common
Stock

 

Paid-in Surplus

 

Retained
Earnings

 

Treasury
Stock

 

Accumulated Other
Comprehensive
Income (Loss)

 

Total

Balance, December 31, 2021

 

$

1,508

 

$

9,708

 

$

72,764

 

$

(10,749)

 

$

(35,938)

 

$

37,293

Add (Deduct):

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

 

 

 

 

(291)

 

 

 

 

 

(291)

 

Other Comprehensive Income (Loss), Net of Tax

 

 

 

 

 

 

 

 

 

(3,292)

 

(3,292)

 

Dividends, $.15 per Common Share

 

 

 

 

 

(489)

 

 

 

 

 

(489)

 

Treasury Stock Acquisition

 

 

 

 

 

 

 

(38)

 

 

 

(38)

Balance, September 30, 2022

 

$

1,508

 

$

9,708

 

$

71,984

 

$

(10,787)

 

$

(39,230)

 

$

33,183

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

 

 

 

 

 

 

Nine Months
Ended
September 30, 2022

 

Nine Months
Ended
September 30, 2021

Operating Activities:

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

$

(291)

 

$

5,039

 

 

 

 

 

Adjustment to Reconcile Net Income to Net Cash Provided by Operating Activities:

 

 

 

 

Pension Contributions (Greater) Less than Expense

 

(2,950)

 

(2,882)

Bad Debt Expense (Recovery)

 

(1)

 

(58)

Depreciation & Amortization

 

4,549

 

4,896

(Gain) Loss on Sales of Equipment

 

(4)

 

(43)

PPP Loan Forgiveness

 

-

 

(1,884)

Change in Assets and Liabilities

 

 

 

 

Dec (Inc) in Accts and Notes Receivable

 

5,266

 

(1,658)

(Inc) in Cost in Excess of Estimated Earnings and Billings

 

-

 

(1,655)

(Inc) in Inventories

 

(7,358)

 

(8,571)

(Inc) in Prepayments

 

(2,742)

 

(152)

(Inc) in Net Investment in Sales-type leases

 

(86)

 

(101)

Dec in Other LT Assets

 

218

 

677

(Dec) Inc in Accounts Payable

 

(3,284)

 

3,156

(Dec) in Accrued Income Tax

 

(1)

 

-

Inc (Dec) in Other Accrued Expenses

 

1,468

 

(3,271)

Inc in Advanced Billings

 

15,494

 

9,012

Inc (Dec) in Billings in Excess of Costs and Estimated Earnings

 

7,554

 

(1,208)

Inc in Lease Liability for Operating

 

220

 

193

Inc in Lease Liability for Financing

 

-

 

152

Principal payments of Lease Liability for Operating

 

(231)

 

(202)

(Dec) In Other Long-Term Liabilities

 

(175)

 

(90)

 Net Cash Provided by Operating Activities

 

$

17,646

 

$

1,350

 

 

 

 

 

Investing Activities

 

 

 

 

Intangibles

 

-

 

(105)

Proceeds from Sales of Equipment

 

11

 

67

Additions to Property, Plant, and Equipment

 

(5,838)

 

(3,588)

 Net Cash (Required) for Investing Activities

 

$

(5,827)

 

$

(3,626)

 

 

 

 

 

Financing Activities

 

 

 

 

Principal payments of Lease Liability for Financing

 

(144)

 

(197)

(Repayment) of Short-Term Borrowings, Net

 

-

 

(595)

(Repayment) of Long-Term Debt

 

(957)

 

(1,250)

Dividends Paid

 

(489)

 

-

Treasury Stock Acquisitions

 

(38)

 

(4,216)

 Net Cash (Required) for Financing Activities

 

$

(1,628)

 

$

(6,258)

 

 

 

 

 

Effect of Exchange Rate Changes

 

(601)

 

(140)

 

 

 

 

 

Net Increase (Decrease) in Cash and Cash Equivalents

 

$

9,590

 

$

(8,674)

 

 

 

 

 

Cash and Cash Equivalents at Beginning of Year

 

11,281

 

22,943

 

 

 

 

 

Cash and Cash Equivalents at End of Quarter

 

$

20,871

 

$

14,269

 

 

 

 

 

PAUL MUELLER COMPANY
SUMMARIZED NOTES TO THE FINANCIAL STATEMENTS
(In thousands)

A. The chart below depicts the net revenue on a consolidating basis for the three months ended September 30.

Three Months Ended September 30

Revenue

 

2022

 

 

2021

 

Domestic

$

35,464

 

$

33,192

 

Mueller BV

$

10,316

 

$

10,148

 

Eliminations

$

(14

)

$

(277

)

Net Revenue

$

45,766

 

$

43,063

 

The chart below depicts the net revenue on a consolidating basis for the nine months ended September 30.

 

 

 

Nine Months Ended September 30

Revenue

 

2022

 

 

2021

 

Domestic

$

97,895

 

$

104,183

 

Mueller BV

$

35,354

 

$

34,369

 

Eliminations

$

(731

)

$

(932

)

Net Revenue

$

132,518

 

$

137,620

 

The chart below depicts the net revenue on a consolidating basis for the twelve months ended September 30.

 

 

 

Twelve Months Ended September 30

Revenue

 

2022

 

 

2021

 

Domestic

$

130,791

 

$

146,092

 

Mueller BV

$

49,805

 

$

46,675

 

Eliminations

$

(1,085

)

$

(1,021

)

Net Revenue

$

179,511

 

$

191,746

 

The chart below depicts the net income on a consolidating basis for the three months ended September 30.

 

 

 

Three Months Ended September 30

Net Income

 

2022

 

 

2021

 

Domestic

$

1,308

 

$

(81

)

Mueller BV

$

(333

)

$

(942

)

Eliminations

$

5

 

$

(19

)

Net Income (Loss)

$

980

 

$

(1,042

)

The chart below depicts the net income on a consolidating basis for the nine months ended September 30.

Nine Months Ended September 30

Net Income

 

2022

 

 

2021

 

Domestic

$

658

 

$

6,367

 

Mueller BV

$

(955

)

$

(1,326

)

Eliminations

$

6

 

$

(2

)

Net Income (Loss)

$

(291

)

$

5,039

 

The chart below depicts the net income on a consolidating basis for the twelve months ended September 30.

Twelve Months Ended September 30

Net Income

 

2022

 

 

2021

 

Domestic

$

1,619

 

$

10,327

 

Mueller BV

$

6

 

$

(16,515

)

Eliminations

$

46

 

$

(48

)

Net Income (Loss)

$

1,671

 

$

(6,236

)


B. Key headlines for the quarter,

  • September 30, 2022 backlog, excluding Mueller Field Operations which was sold on December 31, 2021, held steady at a very solid $139.2 million compared to $141.7 million at June 30, 2022 and $78.4 million at December 31, 2021.   Most business unit backlogs are higher led by the pharmaceutical group which has begun another large project that will continue through 2023.  

  • With the higher backlog, the company initiated a more aggressive referral and bonus program in the U.S. during the summer to attract new workers in this tight employment environment. As of September 30th, the company employed 39 additional workers from the beginning of the year with 18 in production, a 5% increase. Additionally, wages have been increased to remain competitive in the market.

  • Cash has increased $9.6 million in the first nine months to $20.9 million. Advanced deposits from customers in line with the increased backlog, grew $15.5 million. Major uses of cash include $7.4 million increase in inventories and capital expenditures of $5.8 million.

  • Revenue and profits for the first nine months of the year were lower than expected as the Company worked through the older backlog that was not adequately priced for the current inflation. Production continues to be slowed by the shortage or delay of key components.

  • The Company’s pre-tax earnings have been negatively affected by an increase in the LIFO reserve. Pre-tax earnings were reduced by $4.5 million year-to-date and $5.6 million for trailing twelve months. Since January 1, 2021, pre-tax earnings have been negatively affected by $8.5 million. This increase in the reserve is due to inflation and an increase in inventory to produce the larger backlog.

C. Revenue for the trailing three months is up slightly. Revenue in the U.S. was down at nine months and twelve months from the sale of MFO and lower pharmaceutical revenue since the prior year had revenue from the pharmaceutical project that ended in early 2022. In the Netherlands, revenue strengthened slightly but was diminished on the consolidated statements by the strong dollar.

D. Similar to revenue, net income is up at three months but lower at nine months and on twelve months when excluding the goodwill impairment of $15.4 million related to the 2008 acquisition of the Dutch subsidiaries. In the US, the nine-month and twelve-month unfavorable variance is primarily from lower earnings from the pharmaceutical groups and the negative effect from the increase in the LIFO reserve. The prior period results also included the $1.9 million pre-tax profit from the PPP loan forgiveness. On a positive note, the Heat Transfer and the Components groups have grown twelve-month earnings a combined $4.5 million.

E. On August 17, 2022, the Company renewed its U.S. loan agreement with the bank for another year and changed the basis of calculating interest from LIBOR to SOFR+10.

On August 22, 2022, Mueller B.V. amended its loan agreement with the bank by agreeing to pay €3.45 million of the amortizing debt. In return, the bank reduced the financial loan covenants to an annual yearend debt/EBITDA test. The Company loaned Mueller BV €2 million to help make the loan reduction payment to the bank.

F. The pre-tax results for the three months ended September 30, 2022, were unfavorably affected by $0.9 million increase in the LIFO reserve. The pre-tax results for the nine months ended September 30, 2022, were unfavorably affected by $4.5 million increase in the LIFO reserve. The pre-tax results for the twelve months ended September 30, 2022, were unfavorably affected by $5.6 million increase in the LIFO reserve. The pre-tax results for the three months ended September 30, 2021, were unfavorably affected by $1.7 million increase in the LIFO reserve. The pre-tax results for the nine months ended September 30, 2021, were unfavorably affected by $2.8 million increase in the LIFO reserve. The pre-tax results for the twelve months ended September 30, 2021, were unfavorably affected by $2.8 million increase in the LIFO reserve.

G. The consolidated financials are affected by the euro to dollar exchange rate when consolidating Mueller B.V., the Dutch subsidiary. The month end euro to dollar exchange rate was 1.16 for September 2021; 1.13 for December 2021; and 0.98 for September 2022.

This press release contains forward-looking statements that provide current expectations of future events based on certain assumptions. All statements regarding future performance growth, conditions, or developments are forward-looking statements. Actual future results may differ materially from those described in the forward-looking statements due to a variety of factors, including, but not limited to, the factors described in the Company’s Annual Report under “Safe Harbor for Forward-Looking Statements”, which is available at paulmueller.com. The Company expressly disclaims any obligation or undertaking to update these forward-looking statements to reflect any future events or circumstances.

The accounting policies related to this report and additional management discussion and analysis are provided in the 2021 annual report, available at
www.paulmueller.com

Contact Info:  
Ken Jeffries (417) 575-9346 kjeffries@paulmueller.com | https://paulmueller.com